15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering GRI Bio Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $32.00 to $32.00, so the covering firms are broadly aligned. The average target of $32.00 sits 1516% above the current $1.98. The rating mix has stayed broadly stable, with Buy-side ratings easing from 2 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-1.08 next quarter toward $-2.54 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to GRI Bio Inc.
As of Aug, 1 of 1 firms rate GRI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
GRI EPS & revenue forecast
EPS · NEXT QUARTER
$-1.08
Range $-1.21 – $-0.95 · 2 analysts · -97% YoY
Next period, 2 analysts expect GRI Bio Inc. to earn $-1.08 a share (range $-1.21 – $-0.95), versus $-35.84 a year earlier. Full-year consensus is $-4.77, growing to $-2.54 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering GRI Bio Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GRI.
#1
Joseph Pantginis
HC Wainwright & Co. · Rank #298
Buy
$10.00+405.1% to target
Overall win rate
33%
+ Follow
#2
Edward Woo
Ascendiant Capital · Rank #419
Buy
$32.00+1516.2% to target
Overall win rate
25%
+ Follow
#3
MK
Matthew Keller
HC Wainwright & Co.
Buy
$10.00+405.1% to target
Coverage
—
+ Follow
GRI stock forecast FAQ
What is GRI's average 12-month price target?+
The 1 analysts with a live target average $32.00 for GRI Bio Inc. over the next 12 months, ranging from a $32.00 high to a $32.00 low.
Is GRI stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover GRI?+
1 analysts have an active rating on GRI Bio Inc., and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering GRI?+
Among analysts who currently cover GRI, Joseph Pantginis of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #298). Their current call is Buy with a $10.00 target.
What is GRI Bio Inc.'s projected EPS for next quarter?+
The consensus estimate is $-1.08 per share (range $-1.21 – $-0.95) across 2 analysts. Full-year EPS is projected at $-4.77, rising to $-2.54 the following year.
How much revenue is GRI Bio Inc. expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading GRI lately?+
As of Aug, 1 of 1 firms rate GRI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GRI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
